APA (7th ed.) Citation

Editorial, a. (2022). Tasigna advantage in treatment of newly diagnosed chronic myeloid leukemia: Results of «Novartis research». ABV-press.

Chicago Style (17th ed.) Citation

Editorial, article. Tasigna Advantage in Treatment of Newly Diagnosed Chronic Myeloid Leukemia: Results of «Novartis Research». ABV-press, 2022.

MLA (9th ed.) Citation

Editorial, article. Tasigna Advantage in Treatment of Newly Diagnosed Chronic Myeloid Leukemia: Results of «Novartis Research». ABV-press, 2022.